Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Lunetta

Showing results (141-150 of 167) with videos related to

Pageof 17
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|August 21, 2017
<i>TBK1</i> mutations in Italian patients with amyotrophic lateral sclerosis: genetic and functional characterisationLaura Pozzi, Fabiola Valenza, Lorena Mosca, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 22, 2022
Clinimetrics of the cognitive section of the Italian ALS Cognitive Behavioral Screen (ALS-CBS™)Edoardo Nicolò Aiello, Lucia Catherine Greco, Antonino La Tona, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 9, 2019
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trialJesus S Mora, Angela Genge, Adriano Chio, et al.
BMJ Open|August 13, 2017
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial)Eleonora Dalla Bella, Irene Tramacere, Giovanni Antonini, et al.
Journal of Neurology|October 26, 2016
Factors predicting survival in ALS: a multicenter Italian studyAndrea Calvo, Cristina Moglia, Christian Lunetta, et al.
Frontiers in Psychology|February 6, 2023
Standardization of the Italian ALS-CBS™ Caregiver Behavioral QuestionnaireEdoardo Nicolò Aiello, Federica Solca, Lucia Catherine Greco, et al.
Nature Communications|August 17, 2023
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosisJessica Mandrioli, Roberto D'Amico, Elisabetta Zucchi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 18, 2023
The natural history of ALS: Baseline characteristics from a multicenter clinical cohortAlex Berger, Matteo Locatelli, Ximena Arcila-Londono, et al.
Aging and Disease|April 24, 2019
Collagen XIX Alpha 1 Improves Prognosis in Amyotrophic Lateral SclerosisAna C Calvo, Gabriela Atencia Cibreiro, Paz Torre Merino, et al.
Brain : a Journal of Neurology|April 27, 2021
The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trialEleonora Dalla Bella, Enrica Bersano, Giovanni Antonini, et al.
Pageof 17

Showing results (141-150 of 167) with videos related to

Sort By:
Pageof 17
Journal of Neurology, Neurosurgery, and Psychiatry|August 21, 2017
<i>TBK1</i> mutations in Italian patients with amyotrophic lateral sclerosis: genetic and functional characterisationLaura Pozzi, Fabiola Valenza, Lorena Mosca, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 22, 2022
Clinimetrics of the cognitive section of the Italian ALS Cognitive Behavioral Screen (ALS-CBS™)Edoardo Nicolò Aiello, Lucia Catherine Greco, Antonino La Tona, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 9, 2019
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trialJesus S Mora, Angela Genge, Adriano Chio, et al.
BMJ Open|August 13, 2017
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial)Eleonora Dalla Bella, Irene Tramacere, Giovanni Antonini, et al.
Journal of Neurology|October 26, 2016
Factors predicting survival in ALS: a multicenter Italian studyAndrea Calvo, Cristina Moglia, Christian Lunetta, et al.
Frontiers in Psychology|February 6, 2023
Standardization of the Italian ALS-CBS™ Caregiver Behavioral QuestionnaireEdoardo Nicolò Aiello, Federica Solca, Lucia Catherine Greco, et al.
Nature Communications|August 17, 2023
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosisJessica Mandrioli, Roberto D'Amico, Elisabetta Zucchi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 18, 2023
The natural history of ALS: Baseline characteristics from a multicenter clinical cohortAlex Berger, Matteo Locatelli, Ximena Arcila-Londono, et al.
Aging and Disease|April 24, 2019
Collagen XIX Alpha 1 Improves Prognosis in Amyotrophic Lateral SclerosisAna C Calvo, Gabriela Atencia Cibreiro, Paz Torre Merino, et al.
Brain : a Journal of Neurology|April 27, 2021
The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trialEleonora Dalla Bella, Enrica Bersano, Giovanni Antonini, et al.
Pageof 17